JPRN-UMIN000007445已完成未知
Feasibility study of weekly paclitaxel plus gemcitabine for metastatic and recurrent breast cancer with negative HER2 - KBC-SG1104
Kyushu Breast Cancer Study Group0 个研究点目标入组 40 人开始时间: 2012年3月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Allergy to clemohol EL 2.Significant interstitial pneumonia or pulmonary fibrosis seen by chest radiograph and presence of symptoms associated with them 3.Pregnant or lactation women, or women with suspected pregnancy 4.Symptomatic CNS metastasis 5.Infection which needs treatment 6.Poorly controlled pleural effusion or peritoneal effusion 7.Patients judged by the investigator to be unfit for the study
研究者
相似试验
已完成
不适用
Feasibility study of weekly paclitaxel patients with pre-treatment (2 regimens) advanced/recurrent gastric cancer (OGSG 0602)Advanced / Recurrent gastric cancer.JPRN-UMIN000000723OGSG22
已完成
2 期
A phase 2 study of weekly Paclitaxel plus Gemcitabine Combination Chemotherapy in Patients with advanced or metastatic Breast CancerBreast CancerJPRN-UMIN000004741Kinki Multidisciplinary Breast Oncology Group35
招募中
2 期
Improving Performance status of Advanced lung cancer patients with ChemotherapyCTRI/2020/01/022617All India Institute of Medical Sciences
已完成
不适用
Phase 1/2 study of weekly paclitaxel and gemcitabine in patient with HER2 negative recurrent breast cancerBreast CancerJPRN-UMIN000008848Hiroshima Breast Cancer Study Group45
已完成
2 期
Assessment of efficacy of weekly paclitaxel chemotherapy in ovarian cancersAdvanced Ovarian Cancer.Malignant neoplasm of ovaryIRCT2017050333789N1Taleghani Hospital- Shahid Beheshti University of Medical Sciences14